These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11757721)

  • 1. Immunosuppressive therapy for patients with refractory anemia.
    Asano Y; Maeda M; Uchida N; Yokoyama T; Osaki K; Shimoda K; Gondo H; Okamura T; Okamura S; Niho Y
    Ann Hematol; 2001 Nov; 80(11):634-8. PubMed ID: 11757721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin.
    Nakao S; Takami A; Sugimori N; Ueda M; Shiobara S; Matsuda T; Mizoguchi H
    Br J Haematol; 1996 Jan; 92(1):155-8. PubMed ID: 8562389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outcome of immunosuppressive therapy for myelodysplastic syndromes: results of 12 cases from a single institution].
    Miyata A; Yasuda Y; Fujii S; Kikuchi T
    Rinsho Ketsueki; 2002 Oct; 43(10):911-7. PubMed ID: 12462026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive therapy with antithymocyte globulin and cyclosporine for paroxysmal nocturnal hemoglobinuria].
    Nakasone H; Iijima K; Asano H; Nakamura F; Kida M; Izutsu K; Urabe A; Usuki K
    Rinsho Ketsueki; 2008 Jul; 49(7):498-504. PubMed ID: 18709982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow.
    Jonásova A; Neuwirtová R; Cermák J; Vozobulová V; Mociková K; Sisková M; Hochová I
    Br J Haematol; 1998 Feb; 100(2):304-9. PubMed ID: 9488617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
    Broliden PA; Dahl IM; Hast R; Johansson B; Juvonen E; Kjeldsen L; Porwit-MacDonald A; Sjoo M; Tangen JM; Uggla B; Oberg G; Hellstrom-Lindberg E
    Haematologica; 2006 May; 91(5):667-70. PubMed ID: 16670072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
    Forés R; Alcocer M; Cabrera R; Sanjuán I; Briz M; Lago C; Fernández MN
    Sangre (Barc); 1999 Jun; 44(3):199-203. PubMed ID: 10481581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunosuppressive treatment of the myelodysplastic syndrome].
    Larsen MS; Hasselbalch HC
    Ugeskr Laeger; 2003 Jun; 165(26):2654-7. PubMed ID: 12886548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapies in the management of acquired immune-mediated marrow failures.
    Risitano AM
    Curr Opin Hematol; 2012 Jan; 19(1):3-13. PubMed ID: 22143074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Horse anti-thymocyte globulin and eculizumab as concomitant therapeutic approach in an aplastic paroxysmal nocturnal hemoglobinuria patient: go or no-go?
    Alashkar F; Dührsen U; Röth A
    Eur J Haematol; 2016 Oct; 97(4):403-5. PubMed ID: 26990688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
    Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
    Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan.
    Shimamoto T; Tohyama K; Okamoto T; Uchiyama T; Mori H; Tomonaga M; Asano Y; Niho Y; Teramura M; Mizoguchi H; Omine M; Ohyashiki K
    Leuk Res; 2003 Sep; 27(9):783-8. PubMed ID: 12804635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy with antithymocyte globulin and cyclosporine for prolonged marrow failure after hemophagocytic syndrome.
    Kaito K; Otsubo H; Takei Y; Usui N; Kobayashi M
    Ann Hematol; 2003 Nov; 82(11):699-701. PubMed ID: 12961029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia.
    Sugimori C; Yamazaki H; Feng X; Mochizuki K; Kondo Y; Takami A; Chuhjo T; Kimura A; Teramura M; Mizoguchi H; Omine M; Nakao S
    Exp Hematol; 2007 Jan; 35(1):13-20. PubMed ID: 17198869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of the immunosuppressive treatment of patients with severe acquired aplastic anemia: a single institution study.
    Ruiz-Argüelles GJ; Gómez-Rangel JD
    Acta Haematol; 2003; 110(4):184-7. PubMed ID: 14663162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
    Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99.
    Passweg JR; Giagounidis AA; Simcock M; Aul C; Dobbelstein C; Stadler M; Ossenkoppele G; Hofmann WK; Schilling K; Tichelli A; Ganser A
    J Clin Oncol; 2011 Jan; 29(3):303-9. PubMed ID: 21149672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].
    Huang YL; Huang SL; Huang K; Bao R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.